Giant cell arteritis and polymyalgia rheumatica: Are pregnancies a protective factor? A prospective, multicentre case-control study

Rheumatology

Volumn 38, Issue 2, 1999, Pages 118-123

  Duhaut, P ^a,c   Pinede L ^a   Demolombe Rague S ^a   Dumontet, C ^a   Ninet, J ^a   Seydoux, D ^d   Loire, R ^b   Pasquier, J ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b LOUIS PRADEL HOSPITAL   (France)

^c UNIVERSITÉ LYON 1   (France)

^d Soc de Secours Miniere de la Loire   (France)

Author keywords

Allo immunization; Blood transfusion; Giant cell arteritis; Polymyalgia rheumatica; Pregnancy; Protective factor

Indexed keywords

ADULT; AGED; ARTICLE; BIOPSY; BLOOD TRANSFUSION; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GIANT CELL ARTERITIS; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PARITY; PERIPHERAL VASCULAR DISEASE; PREGNANCY; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; SMOKING;

AGED; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; POLYMYALGIA RHEUMATICA; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TEMPORAL ARTERITIS;

EID: 0032756307     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.2.118     Document Type: Article

References (31)

1. Bengtsson BA, Malmvall BE. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidence of different clinical presentations and eye complications. Arthritis Rheum 1981;24:899-904.
2. Barrier J, Pion P, Massari R, Peltier P, Rojouan J, Grolleau JY. Approche épidémiologique de la maladie de Horton dans le département de Loire-Atlantique. 110 cas en 10 ans (1970-1979). Rev Med Int 1982;3:13-20.
3. Boesen P, Sorensen FS. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982-1985. Arthritis Rheum 1987;30:294-9.
4. Machado EBV, Michet CJ, Ballard DJ, Hunder GG, Beard CM, Chu CP et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted county, Minnesota, 1950-1985. Arthritis Rheum 1988;31:745-9.
5. O'Brien JP. A new risk factor and other actinic radiation in giant cell arteritis and atherosclerosis. Int J Dermatol 1987;26:345-8.
6. Machado EBV, Gabriel SE, Beard CM, Michet CJ, O'Fallen WM, Ballard DJ. A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease? Int J Epidemiol 1989;18:836-41.
7. Duhaut P, Pinède L, Demolombe-Ragué S, Loire R, Seydoux D, Ninet J et al. Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Arthritis Rheum 1998;41:1960-5.
8. Barrier J, Bignon J, Soulillou J, Grolleau J. Increased prevalence of HLA DR4 in giant cell arteritis. N Engl J Med 1981;305:104-5.
9. Calamia KT, Moore SB, Elveback LR, Hunder GG. HLA DR 4 locus antigen in polymyalgia rheumatica and giant cell arteritis. J Rheumatol 1981;8:993-6.
10. Armstrong RD, Behn A, Myles A, Panayi GS, Welsh KI. Histocompatibility antigens in polymyalgia rheumatica and giant cell arteritis. J Rheumatol 1983;10:659-61.
11. Cid MC, Ercilla G, Vilaseca J, Sanmarti R, Villalta J, Ingelmo M et al. Polymyalgia rheumatica: a syndrome associated with HLA-DR4 antigen. Arthritis Rheum 1998;31:678-82.
12. Ninet J, Gebuhrer L, Betuel H, Bachet P, Girard-Madoux MH, Pasquier J. Immunogénétique de la maladie de Horton et de la pseudopolyarthrite rhizomélique. J Mal Vasc 1989;14:128-36.
13. Barrier JH, De Haldat de Lys F, Billaudel S, Peltier P, Ponge T. Herpes zoster serological study and cranial giant cell arteritis. J Rheumatol 1986;13:6-7.
14. Buchwald D, Sullivan JL, Leddy S, Komaroff AL. 'Chronic Epstein-Barr virus infection' syndrome and polymyalgia rheumatica. J Rheumatol 1988;15:479-82.
15. Cimmino MA, Grazi G, Balistreri M, Accardo S. Increased prevalence of antibodies to adenovirus and respiratory syncytial virus in polymyalgia rheumatica. Clin Exp Rheumatol 1993;11:309 13.
16. Nelson JL. Maternal-fetal immunology and autoimmune disease. Is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum 1996;39:191-4.
17. Bos G, Majoor G, Slaaf D, Reneman R, Van Breda Vriesman P. In vivo demonstration of microvascular pathology by intravital microscopy in experimental chronic graft-versus-host disease; analogy with scleroderma. J Rheumatol 1988;15:1339-45.
18. Furst DE, Clements PJ, Graze P, Gale R, Roberts N. A syndrome resembling progressive systemic sclerosis after bone marrow transplantation: a model for scleroderma? Arthritis Rheum 1979;22:904-10.
19. Chosidow O, Bagot M, Vernant FP, Roujeau FC, Cordonnier C, Kuentz M et al. Sclerodermatous chronic graft-versus-host disease. J Am Acad Dermatol 1992;26:49-55.
20. Artlett CM, Smith JB, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998;338:1186-91.
21. Silman A, Kay A, Brennan P. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum 1992;35:152-5.
22. Pritchard ME. An examination of the role of female hormones and pregnancy as risk factors for rheumatoid arthritis, using a male population as control group. Br J Rheumatol 1992;31:395-9.
23. Jorgenson C, Picot MC, Bologna C, Sany J. Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis. Ann Rheum Dis 1996;55:94-8.
24. Symmons DP, Bankhead CRN, Harrison BJ, Brennan P, Barrett EM, Scott DG et al. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum 1997;40:1955-61.
25. Walton K, Dyer PA, Grennan DM, Haeney M, Harris R. Clinical features, autoantibodies and HLA-DR antigens in rheumatoid arthritis. J Rheumatol 1985;12:223-6.
26. Suarez-Almazor ME, Tao S, Moustarah F, Russell AS, Maksymowych W. HLA-DR1, DR4, and DRB1 disease subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city wide community based study. J Rheumatol 1995;22:2027-33.
27. McDonnel PJ, Moore GW, Miller NR, Miller NR, Hutchins GM, Grenn WR. Temporal arteritis. A clinicopathologic study. Ophthalmology 1986;93:518-30.
28. Hunder GG, Bloch DA, Michel BA et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
29. Kaplan JR, Adams MR, Clarkson TB, Manuck SB, Shively CA, Williams JK. Psychosocial factors, sex differences, and atherosclerosis: lessons from animal models. Psychosom Med 1996;58:598 611.
30. Kaplan JR, Adams MR, Clarkson TB, Manuck SB, Shively CA. Social behavior and gender in biomedical investigations using monkeys: studies in atherogenesis. Lab Anim Sci 1991;41:334-43.
31. Clarkson TB, Adams MR, Kaplan JR, Shively CA, Koritnik DR. From menarche to menopause: coronary artery atherosclerosis and protection in cynomolgus monkeys. Am J Obstet Gynecol 1989;160:1280-5.